These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29314393)

  • 1. Global Cerebral Atrophy Detected by Routine Imaging: Relationship with Age, Hippocampal Atrophy, and White Matter Hyperintensities.
    Al-Janabi OM; Panuganti P; Abner EL; Bahrani AA; Murphy R; Bardach SH; Caban-Holt A; Nelson PT; Gold BT; Smith CD; Wilcock DM; Jicha GA
    J Neuroimaging; 2018 May; 28(3):301-306. PubMed ID: 29314393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of white matter hyperintensities, medial temporal lobe atrophy and cortical atrophy on outcome, seven to twelve years after ECT in severely depressed geriatric patients.
    Oudega ML; Dols A; Adelerhof I; Rozing M; Wattjes MP; Comijs HC; Barkhof F; Eikelenboom P; Stek ML; van Exel E
    J Affect Disord; 2015 Oct; 185():144-8. PubMed ID: 26186529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medial Temporal Atrophy in Amyloid-Negative Amnestic Type Dementia Is Associated with High Cerebral White Matter Hyperintensity.
    Wong BYX; Yong TT; Lim L; Tan JY; Ng ASL; Ting SKS; Hameed S; Ng KP; Zhou JH; Kandiah N
    J Alzheimers Dis; 2019; 70(1):99-106. PubMed ID: 31177215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. White matter hyperintensities and imaging patterns of brain ageing in the general population.
    Habes M; Erus G; Toledo JB; Zhang T; Bryan N; Launer LJ; Rosseel Y; Janowitz D; Doshi J; Van der Auwera S; von Sarnowski B; Hegenscheid K; Hosten N; Homuth G; Völzke H; Schminke U; Hoffmann W; Grabe HJ; Davatzikos C
    Brain; 2016 Apr; 139(Pt 4):1164-79. PubMed ID: 26912649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medial temporal lobe atrophy relates to executive dysfunction in Alzheimer's disease.
    Oosterman JM; Oosterveld S; Rikkert MG; Claassen JA; Kessels RP
    Int Psychogeriatr; 2012 Sep; 24(9):1474-82. PubMed ID: 22717328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective Cognitive Decline Is Associated with Greater White Matter Hyperintensity Volume.
    van Rooden S; van den Berg-Huysmans AA; Croll PH; Labadie G; Hayes JM; Viviano R; van der Grond J; Rombouts SARB; Damoiseaux JS
    J Alzheimers Dis; 2018; 66(3):1283-1294. PubMed ID: 30412485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medial temporal lobe atrophy is independently associated with behavioural and psychological symptoms in Alzheimer's disease.
    García-Alberca JM; Florido M; Cáceres M; Sánchez-Toro A; Lara JP; García-Casares N
    Psychogeriatrics; 2019 Jan; 19(1):46-54. PubMed ID: 30084177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Hyperintensities and Hippocampal Atrophy in Relation to Cognition: The 90+ Study.
    Legdeur N; Visser PJ; Woodworth DC; Muller M; Fletcher E; Maillard P; Scheltens P; DeCarli C; Kawas CH; Corrada MM
    J Am Geriatr Soc; 2019 Sep; 67(9):1827-1834. PubMed ID: 31169919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis.
    Rhodius-Meester HFM; Benedictus MR; Wattjes MP; Barkhof F; Scheltens P; Muller M; van der Flier WM
    Front Aging Neurosci; 2017; 9():117. PubMed ID: 28536518
    [No Abstract]   [Full Text] [Related]  

  • 14. Do cardiovascular risk factors explain the link between white matter hyperintensities and brain volumes in old age? A population-based study.
    Wang R; Fratiglioni L; Laveskog A; Kalpouzos G; Ehrenkrona CH; Zhang Y; Bronge L; Wahlund LO; Bäckman L; Qiu C
    Eur J Neurol; 2014 Aug; 21(8):1076-1082. PubMed ID: 24313901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.
    Akinyemi RO; Firbank M; Ogbole GI; Allan LM; Owolabi MO; Akinyemi JO; Yusuf BP; Ogunseyinde O; Ogunniyi A; Kalaria RN
    BMC Res Notes; 2015 Oct; 8():625. PubMed ID: 26519155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Spectrum of Subcortical Hyperintensities and Cognitive Decline.
    Chen YC; Tsao HH; Chu YC; Wang JJ; Lee JD; Chang PY; Hsu WC
    J Neuropsychiatry Clin Neurosci; 2018; 30(2):130-138. PubMed ID: 29061091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter lesions and temporal atrophy are associated with cognitive and neuropsychiatric symptoms in patients with hypertension and Alzheimer's disease.
    García-Alberca JM; Mendoza S; Gris E; Royo JL; Cruz-Gamero JM; García-Casares N
    Int J Geriatr Psychiatry; 2020 Nov; 35(11):1292-1300. PubMed ID: 32584440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medial temporal lobe atrophy is underreported and may have important clinical correlates in medical inpatients.
    Torisson G; van Westen D; Stavenow L; Minthon L; Londos E
    BMC Geriatr; 2015 Jun; 15():65. PubMed ID: 26076825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.